DIANTHUS THERAPEUTICS INC (DNTH) Stock Earnings & Estimates
USA - NASDAQ:DNTH - US2528281080 - Common Stock
36 USD
+0.35 (+0.98%)
35.49 USD
-0.51 (-1.42%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.826M | 6.235M 120.63% | 2.406M -61.41% | 2.153M -10.52% | 2.843M 32.05% | 38.217M 1,244.25% | 191.61M 401.37% | 529.65M 176.42% | 806.08M 52.19% | 1.03B 27.78% | ||
| EBITDA YoY % growth | -78.97M -8.67% | -47.819M 39.45% | -101.452M -112.16% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -80.9M -8.31% | -48.174M 40.45% | -101.864M -111.45% | -144.31M -41.67% | -169.467M -17.43% | -198.456M -17.11% | -195.023M 1.73% | -90.985M 53.35% | 148.13M 262.81% | 331.93M 124.08% | 474.69M 43.01% | |
| Operating Margin | N/A | -1,704.67% | -1,633.74% | -5,997.91% | -7,871.18% | -6,980.50% | -510.30% | -47.48% | 27.97% | 41.18% | 46.09% | |
| EPS YoY % growth | -20.64 -1,475.57% | -12.97 37.16% | -2.60 79.95% | -3.46 -33.19% | -3.62 -4.39% | -3.92 -8.31% | -3.44 12.21% | -4.03 -17.21% | 1.40 134.68% | 0.54 -61.31% | 3.48 543.40% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.90 -21.87% | -0.85 -5.36% | -0.87 -5.73% | -0.92 -4.82% | -0.99 -9.87% | -0.96 -12.01% | -0.74 14.12% | -0.77 17.06% | -0.79 20.74% | -0.80 16.77% |
| Revenue Q2Q % growth | 586.908K -72.98% | 485.928K -51.36% | 372.81K -67.94% | 389.813K 101.98% | 345.372K -41.15% | 345.372K -28.93% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -36.61M -22.44% | -38.235M -19.80% | -39.878M -20.20% | -41.76M -19.56% | -43.647M -19.22% | -44.906M -17.45% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.88 -72.55% | -0.89 | 0.01 | 1.02% |
| Q1 2025 Q2Q % growth | -0.82 -51.85% | -0.87 | 0.05 | 5.31% |
| Q4 2024 Q2Q % growth | -0.81 -14.08% | -0.87 | 0.06 | 6.67% |
| Q3 2024 Q2Q % growth | -0.74 80.42% | -0.61 | -0.13 | -22.05% |
| Q2 2024 Q2Q % growth | -0.51 36.25% | -0.56 | 0.05 | 8.35% |
| Q1 2024 Q2Q % growth | -0.54 92.97% | -0.45 | -0.09 | -20.87% |
| Q4 2023 Q2Q % growth | -0.71 86.95% | -1.03 | 0.32 | 31.08% |
| Q3 2023 Q2Q % growth | -3.78 12.50% | -0.57 | -3.21 | -561.76% |
| Q2 2023 Q2Q % growth | -0.80 82.76% | -3.10 | 2.30 | 74.20% |
| Q1 2023 Q2Q % growth | -7.68 -23.08% | -6.69 | -0.99 | -14.78% |
| Q4 2022 Q2Q % growth | -5.44 -1,548.48% | -4.41 | -1.03 | -23.46% |
| Q3 2022 Q2Q % growth | -4.32 -1,340.00% | -4.90 | 0.58 | 11.76% |
| Q2 2022 Q2Q % growth | -4.64 -1,350.00% | -5.39 | 0.75 | 13.84% |
| Q1 2022 Q2Q % growth | -6.24 -1,633.33% | -5.11 | -1.13 | -22.21% |
| Q4 2021 Q2Q % growth | -0.33 13.16% | -0.33 | 0.00 | -0.58% |
| Q3 2021 Q2Q % growth | -0.30 18.92% | -0.33 | 0.03 | 10.41% |
| Q2 2021 Q2Q % growth | -0.32 33.33% | -0.39 | 0.07 | 17.00% |
| Q1 2021 Q2Q % growth | -0.36 29.41% | -0.41 | 0.05 | 12.20% |
| Q4 2020 Q2Q % growth | -0.38 35.59% | -0.42 | 0.04 | 10.32% |
| Q3 2020 Q2Q % growth | -0.37 31.48% | -0.46 | 0.09 | 19.17% |
| Q2 2020 Q2Q % growth | -0.48 | -0.55 | 0.07 | 12.57% |
| Q1 2020 Q2Q % growth | -0.51 -15.91% | -0.61 | 0.10 | 15.79% |
| Q4 2019 Q2Q % growth | -0.59 | -0.60 | 0.01 | 2.35% |
| Q3 2019 Q2Q % growth | -0.54 | -0.55 | 0.01 | 2.36% |
| Q2 2019 Q2Q % growth | -0.48 | -0.54 | 0.06 | 10.70% |
| Q1 2019 Q2Q % growth | -0.44 | -0.59 | 0.15 | 24.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 193K -89.64% | 881.617K | -688.617K | -78.11% |
| Q1 2025 Q2Q % growth | 1.163M 33.07% | 820.386K | 342.614K | 41.76% |
| Q4 2024 Q2Q % growth | 999K 118.60% | 876.894K | 122.106K | 13.92% |
| Q3 2024 Q2Q % growth | 2.172M 135.06% | 661.47K | 1.511M | 228.36% |
| Q2 2024 Q2Q % growth | 1.863M | 329.205K | 1.534M | 465.91% |
| Q1 2024 Q2Q % growth | 874K | 473.535K | 400.465K | 84.57% |
| Q4 2023 Q2Q % growth | 457K | 312.12K | 144.88K | 46.42% |
| Q3 2023 Q2Q % growth | 924K | 255K | 669K | 262.35% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.02% | 1.04% | -1.74% |
| Revenue | 0% | -36.8% | 0% | -37.15% |